Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosorbide mononitrate extended-release add-on for refractory isolated systolic hypertension in older adults
2012-002988-10Phase 4Completed
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario de Getafe
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in refractory isolated systolic hypertension (RISH) comparing Isosorbide mononitrate extended-release add-on with Placebo add-on (2 arms). Primary endpoint: Primary: Change in office pulse pressure. Started Sep 2012; status: completed.
02
Drugs
isosorbide mononitrate
03
Conditions
refractory isolated systolic hypertension (RISH)
Beyond the preview
Go deeper on 2012-002988-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002988-10.